8 citations
,
March 2019 in “Drugs - Real World Outcomes” Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.
7 citations
,
September 2007 Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.
6 citations
,
October 2012 in “PubMed” The combined treatment of 3% minoxidil and 0.1% finasteride is more effective in improving hair loss than 3% minoxidil alone, with similar side effects.
5 citations
,
September 2020 in “DOAJ (DOAJ: Directory of Open Access Journals)” The hair serum effectively reduced hair fall and improved hair growth without causing any skin issues.
4 citations
,
July 2019 in “Journal of cosmetic dermatology” Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.
2 citations
,
May 2024 in “International Journal of Medical Arts” Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.
2 citations
,
October 2023 in “Cosmetics” Latanoprost effectively and safely promotes eyelash growth.
2 citations
,
August 2019 in “Asian journal of pharmaceutical and clinical research” Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.
1 citations
,
July 2023 in “Archives of dermatological research” Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.
1 citations
,
July 2023 in “Cureus” Cetosomal minoxidil alone and with finasteride is effective and well-tolerated for hair loss treatment.
1 citations
,
February 2017 in “PubMed” The supplement may help hair growth and is safe, but more research is needed.
July 2026 in “Health Science Reports” Combining microneedling with mesotherapy, especially with hyaluronic acid, finasteride, and latanoprost, effectively improves hair growth in androgenic alopecia.
July 2026 in “Journal of the American Academy of Dermatology” Upadacitinib is effective and safe for long-term treatment of alopecia areata, especially for those with an atopic background.
May 2026 in “Indian Journal of Dermatology” Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.
May 2026 in “SKIN The Journal of Cutaneous Medicine” The gummy supplement effectively promotes hair growth and is safe for women with hair thinning.
September 2025 in “JAAD International” Thrice-weekly dutasteride improved hair density and thickness more than twice-weekly, but not hair count compared to daily finasteride.
August 2025 in “International Journal of Scientific Research” Oral minoxidil effectively promotes hair growth in men with hair loss, but caution is needed for older or heart-risk patients.
July 2025 in “Journal of Investigative Dermatology” Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.
July 2025 in “International Journal of Dermatology” Topical finasteride may be safer than oral finasteride, but more research is needed.
May 2025 in “International Journal of Biological and Pharmaceutical Sciences Archive” Narasimham Hair Oil effectively promotes hair regrowth and scalp health without side effects.
March 2025 in “Journal of the European Academy of Dermatology and Venereology” Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.
January 2025 in “Recent Patents on Anti-Cancer Drug Discovery” The treatment showed high response rates and was well-tolerated, potentially extending patient survival.
January 2025 in “International Journal of Trichology” Topical spironolactone and minoxidil both effectively treat female hair loss, but spironolactone has fewer side effects.
October 2024 in “Asian Journal of Pharmaceutical and Clinical Research” Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.
August 2024 in “International Journal of Research in Dermatology” Indulekha Svetakutaja Hair Oil effectively reduces dandruff and improves scalp health.
August 2024 in “Journal of Cosmetic Dermatology” CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.
June 2024 in “The Open dermatology journal” The herbal extract is as effective and safe as 3% minoxidil for treating hair loss.
10% minoxidil improves frontal hair count more than 5% but has more side effects.
May 2024 in “Australasian journal of dermatology” Bicalutamide is more effective and safer than spironolactone for treating female hair loss.
The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.